Tusamitamab is an IgG1 моноклональный антитело that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized антитело-препарат conjugate (ADC) that combines Tusamitamab and DM4 (a мощный maytansine derivative).
Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.